https //covid 19cc.nic.in : COVID19 RT-PCR, Rapid Antibody and Rapid Antibody Tests

https //covid 19cc.nic.in :

The collection of correct data timely is most important during these tough times. The data related to COVID19 RT-PCR, Rapid Antibody and Rapid Antibody Tests is being collected by Government of India with the help of authorized collection centre persons spread throughout the country.

|amp|

covid19cc

The portal at https://covid19cc.nic.in is primarily for entry of authorized person details so that they may use the mobile Apps for transferring RT-PCR, Rapid Antigen and Rapid Antibody tests data to ICMR portal for probable +ve/-ve cases, through their mobile phones. Only authorized Government officials will use this portal.

Download Mobile Apps

RT PCR patient categories

A. Routine surveillance in containment zones and screening at points of entry:
1. All symptomatic (ILI symptoms) cases including health care workers and frontline workers.
2. All asymptomatic direct and high-risk contacts (in family and workplace, elderly ≥ 65 years of age, immunocompromised, those with co-morbidities etc.) of a laboratory confirmed case to be tested once between day 5 and day 10 of coming into contact.
3. All asymptomatic high-risk individuals (elderly ≥ 65 years of age, those with comorbidities etc.) in containment zones.

B. Routine surveillance in non-containment areas:

4. All symptomatic (ILI symptoms) individuals with history of international travel in the last 14 days.
5. All symptomatic (ILI symptoms) contacts of a laboratory confirmed case.
6. All symptomatic (ILI symptoms) health care workers / frontline workers involved in containment and mitigation activities.
7. All symptomatic ILI cases among returnees and migrants within 7 days of illness.
8. All asymptomatic high-risk contacts (contacts in family and workplace, elderly ≥ 65 years of age, those with co-morbidities etc. [RAT is recommended as the first choice of test in order of priority]

C. In Hospital Settings:

9. All patients of Severe Acute Respiratory Infection (SARI).
10. All symptomatic (ILI symptoms) patients presenting in a healthcare setting.
11. Asymptomatic high-risk patients who are hospitalized or seeking immediate hospitalization such as immunocompromised individuals, patients diagnosed with malignant disease, transplant patients, patients with chronic co-morbidities, elderly ≥ 65 years.
12. Asymptomatic patients undergoing surgical / non-surgical invasive procedures (not to be tested more than once a week during hospital stay).
13. All pregnant women in/near labor who are hospitalized for delivery.
14. All symptomatic neonates presenting with acute respiratory / sepsis like illness. (Features suggestive of acute respiratory illness in a neonate are respiratory distress or apnea with or without cough, with or without fever. Neonates may also manifest with only non-respiratory symptoms like fever, lethargy, poor feeding, seizures or diarrhea).
15. Patients presenting with atypical manifestations [stroke, encephalitis, hemoptysis, pulmonary embolism, acute coronary symptoms, Guillain Barre syndrome, Multiple Organ Dysfunction Syndrome, progressive gastrointestinal symptoms, Kawasaki Disease (in pediatric age group)] based on the discretion of the treating physician.

D. Testing on demand (State Governments to decide simplified modalities):

16. All individuals undertaking travel to countries/Indian states mandating a negative COVID-19 test at point of entry. 17. All individuals who wish to get themselves tested.

Be the first to comment

Leave a Reply

Your email address will not be published.


*